Amlodipine labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
{| | {| | ||
| [[image:norvasc8.jpg| | |[[image:norvasc8.jpg|400px|thumb]] | ||
|} | |} | ||
Line 25: | Line 24: | ||
{| | {| | ||
|[[image:norvasc9.jpg|400px|thumb]] | |||
| [[image:norvasc9.jpg|400px|thumb]] | |||
|} | |} | ||
Revision as of 01:30, 13 March 2014
Amlodipine |
---|
NORVASC®, AMLODIPINE®, AMLODIPINE BESYLATE® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Dosage Forms and Strengths |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Amlodipine |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL - 5 mg Tablets
Norvasc® 5 mg*
Amlodipine Besylate
10 Tablets
PRINCIPAL DISPLAY PANEL - 10 mg Tablets
Norvasc® 10 mg*
Amlodipine Besylate
10 Tablets
References
- ↑ "NORVASC (AMLODIPINE BESYLATE) TABLET [CARDINAL HEALTH]". Retrieved 6 March 2014.